Berta Segura-Collar

11PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Tumour immunologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 28, 2026
Segmentation Methodologies for the Construction of Hyperspectral Cell Nuclei Databases in Histopathology.

Gonzalo Rosa-Olmeda, Sara Hiller-Vallina, Manuel Villa

|Oct 20, 2025
Oligodendrogliomas, cyclin pathway after the introduction of the molecular 2021 World Health Organization (WHO) criteria.

Maria Angeles Vaz-Salgado, Juan M Sepulveda, Julie Earl

|Apr 10, 2025
The TRIB2-DNMT1 Pathway Generates an Immune-Cold Microenvironment in Glioblastoma, and Its Inhibition Promotes Immunotherapy.

Berta Segura-Collar, Blanca Cómitre-Mariano, Denisse Alcivar López

|Mar 20, 2024
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models.

Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García

|Feb 27, 2024
Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastoma.

Sara Hiller-Vallina, Lucia Mondejar-Ruescas, Marta Caamaño-Moreno

Pageof 2